1-Methyl-5-nitro-1H-benzo[d][1,2,3]triazole

Catalog No. :
ACTIPC968
CAS No. :
25877-34-3
Molecular Formula :
C7H6N4O2
Molecular Weight :
178.15

IUPAC Name:1-methyl-5-nitro-1H-benzo[d][1,2,3]triazole

1-Methyl-5-nitro-1H-benzo[d][1,2,3]triazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$60.00Login to see priceIn stockInquiry
1g95%$167.00Login to see priceIn stockInquiry
5g95%$585.00Login to see priceIn stockInquiry
25g95%$2619.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Methyl-5-nitro-1H-benzo[d][1,2,3]triazole
IUPAC Name1-methyl-5-nitro-1H-benzo[d][1,2,3]triazole
MDL No.MFCD00972294
Molecular FormulaC7H6N4O2
Molecular Weight178.15
SMILESO=[N+](C1=CC=C(N(C)N=N2)C2=C1)[O-]
InChI KeyBQPFSSQRLBUMQC-UHFFFAOYSA-N
Synonym1-Methyl-5-nitro-1H-benzotriazole;1-Methyl-5-nitro-1H-1,2,3-benzotriazole;1-methyl-5-nitrobenzotriazole;1H-Benzotriazole, 1-methyl-5-nitro-;1-Methyl-5-nitro-1H-benzo[d][1,2,3]triazole
CAS No.25877-34-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACTIPC968 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXSWI475 route compound structure diagram
    ACXSWI47541939-61-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTIPC968 route product structure diagram
    ACTIPC96825877-34-3 In Stock
Inquiry

2. ACTIPC968 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTIPC968 route product structure diagram
    ACTIPC96825877-34-3 In Stock
Inquiry

Comments (0)